Search
Search filters
Type
Audience
Category
Issue
Last updated
Displaying 1 - 2 of 2 items.
Rapid antigen test kits and potential exposure to hazardous substances
AlertPublic advisory | 2022-02-24
BEOVU (brolucizumab) – Risk of Intraocular Inflammation, Retinal Vasculitis and/or Retinal Vascular Occlusion
AlertHealth professional risk communication | 2022-02-03